European Vaccines Market

Research Overview

Participants in the European Vaccines Market Need to Counter Fragmentation to Witness Greater Growth

While Europe has traditionally been a strong centre for vaccine manufacturers, the market for vaccine products continues to be superior in terms of sales in North America mainly because of higher profits and consistent demand. Moreover, the fragmentation in the European market and stringent pricing controls act as deterrents for greater revenue generation. Nevertheless, encouraging market trends such as increasing interest towards consolidation, introduction of novel vaccine products and crucial initiatives from regional governments are driving the European vaccines market.

This Frost & Sullivan research service provides an overview of and an outlook for the vaccines market in Europe, detailing revenue forecasts by region and providing market share analyses. This study looks into the major vaccines segments pertaining to paediatric and adult, measles-mumps-rubella, diphtheria-tetanus-pertussis (DTP), pneumococcal, meningococcal, hepatitis and influenza. It further elaborates on the trends in the global vaccines market.

Launch of Novel Vaccines Drives the Market in Europe

"While the number of diseases covered by the vaccines available in Europe have not increased significantly in the past few years, the introduction of novel and improved products - especially for new diseases - such as the human papilloma virus (HPV) and rotavirus ones are driving the overall market," says the analyst of this research service. These vaccines are aimed at the adolescent and adult groups, a strategy that is likely to be followed by the vaccine manufacturers in Europe for the long term. Further, enterprises in Western countries are focusing more on preventive medicines and life cycle management, a development that could stimulate the region’s vaccine market.

Presence of Major Vaccine Companies Secure Europe’s Position in the Global Vaccines Market

"The European vaccines market has been successfully maintaining its share of the global market, mainly due to its strength in manufacturing activities," highlights the analyst. "Major global companies have their headquarters in Europe and significantly contribute to the continent’s ability to hold on to almost one-third of the global market share." The European market for vaccines was valued at $3.20 billion in 2005 and is likely to grow to $6.58 billion by 2012, demonstrating a compound annual growth rate (CAGR) of 10.8 per cent during this period.

Overall, various vaccine products such as MMR + Varicella, Herpes Zoster, Rotavirus, HPV and Meningococcal infections (A, C, Y, W135) conjugate vaccines are expected to be developed widely within the next five years. Moreover innovative vaccines to combat Hepatitis C, HIV, Tuberculosis, Respiratory Syncitial Virus (RSV), Helicobacter Pylori, Cytomegalovirus, Epstein-Barr virus, Meningococcal Meningitis B and West Nile virus are likely to make their presence felt in the European vaccines market within the next decade.

Benefits of this Service

Segment and Product Analysis

This research service provides a comprehensive and comparative analysis of the products available in the European vaccines market, including strengths, weaknesses, opportunities and threats (SWOT) analysis for some major products in both the paediatric and adult vaccines segments.

Analysis of European Vaccines Market

This research service includes a comprehensive analysis of the European vaccines market, including revenue forecasts until 2012.

Global Trends

This research service includes analysis of the global vaccines market, thus providing an overview of the market trends on a global perspective.

Decision Support Databases

This research service includes decision support databases providing information on incidences of various diseases such as mumps, measles, pertussis, diphtheria, hepatitis A, hepatitis B, rubella and tetanus.

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

• Paediatric and adult vaccines
• Immunisation profile - European region
• Measles-mumps-rubella vaccines
• Diphtheria-tetanus-pertussis (DTP) vaccines
• Pneumococcal vaccines
• Meningococcal and other vaccines
• Hepatitis vaccines
• Influenza vaccines

What's Included

• Segment and product analysis - paediatric and adult segments
• European vaccines market forecasting analysis
• Global trends
• Strategic analysis and recommendations
• Market dynamics